Custom service
Nanodisc System for Membrane Protein
A patch of bilayer, held in solution, sized to the protein.
A nanodisc is a disc of lipid bilayer whose edge is held by two belt proteins, presenting a membrane protein in a native-like lipid environment while remaining soluble and monodisperse. It is the format that lets a membrane protein behave like a soluble protein — injectable, SEC-analysable, surface-immobilisable — without leaving the bilayer it needs.
Assembly is a controlled stoichiometry problem. The classic MSP system uses engineered apolipoprotein A-I variants whose length sets the disc diameter, so the bilayer patch can be sized to the protein. The protein, lipids and MSP are assembled with detergent removal — by Bio-Beads, dialysis or resin — and the product is purified by SEC to isolate correctly assembled discs from aggregates and empty discs.
Alternatives exist for cases where MSP is not ideal. SMALP discs use a styrene-maleic acid copolymer to extract protein directly from cell membranes with their native lipids, which preserves a lipid composition no reconstitution can replicate. Peptide discs offer a smaller, defined belt for NMR-scale work. The choice is made against the target and the assay, and each format is validated the same way: size, protein-to-lipid ratio, monodispersity and function.
Nanodiscs are the format of choice for conformational antibody generation against native membrane surfaces, for SPR and BLI assays that need an oriented, stable presentation, and for structural work on small membrane proteins.
They are less suitable for transporters and channels whose function needs a sealed compartment — proteoliposomes serve those — and for very large complexes that exceed the disc diameter.
Each assembly is delivered with SEC profile, size by SEC-MALS or DLS, protein-to-lipid ratio, belt identity, and a functional measurement where a readout exists. Empty disc content is quantified, since it competes for surface area in immobilised assays.
Service Highlights
- Sized to the protein. MSP variants from MSP1D1 to MSP1E3D1 and custom lengths, so the bilayer patch matches the target rather than the default.
- Native lipid extraction. SMALP solubilisation pulls the protein out of cell membranes with its endogenous lipid complement.
- Assembly quality control. SEC purification separates filled discs from empty discs and aggregates, with ratios measured by protein and lipid assay.
- Composition control. Lipid mixtures assembled at defined ratios — cholesterol, PIP2, cardiolipin — matched to the target's requirements.
- Assay-ready. Discs formatted for SPR, BLI, SEC, DLS and immobilisation on sensor surfaces.
- Function verified. Ligand binding or activity measured on the assembled discs before release.
How the work runs
Format selection
MSP, SMALP or peptide disc chosen against the target size, required lipids and downstream assay.
Lipid and belt design
Lipid composition and MSP variant selected for the target, with the disc diameter matched to the protein.
Assembly
Protein, lipid and belt combined and detergent removed by Bio-Beads or dialysis under controlled conditions.
Purification
SEC isolation of correctly assembled discs, with empty discs and aggregates quantified.
Characterisation
Size by SEC-MALS or DLS, protein-to-lipid ratio, and belt identity by mass spectrometry.
Functional QC
Ligand binding or activity on the assembled discs, compared with the detergent format where possible.
Specifications & timeline
- Disc types
- MSP nanodiscs (MSP1D1, MSP1E1–E3, custom), SMALP, peptide discs
- Lipids
- POPC, POPE, cholesterol, CHS, cardiolipin, PIP2 and defined mixtures
- Diameter
- 9–17 nm depending on MSP variant
- Scale
- 0.1–2 mg protein in discs per batch
- Timeline
- 2–4 weeks including assembly and QC
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.